BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Mladen Korbelik, Wei Zhang, Soroush Merchant. Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 releaseCancer Immunology, Immunotherapy 2011; 60(10): 1431 doi: 10.1007/s00262-011-1047-x
2
Jitka Fucikova, Irena Moserova, Linda Urbanova, Lucillia Bezu, Oliver Kepp, Isabelle Cremer, Cyril Salek, Pavel Strnad, Guido Kroemer, Lorenzo Galluzzi, Radek Spisek. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerFrontiers in Immunology 2015; 6 doi: 10.3389/fimmu.2015.00402
3
Lenka Kasikova, Michal Hensler, Iva Truxova, Petr Skapa, Jan Laco, Lucie Belicova, Ivan Praznovec, Sarka Vosahlikova, Michael J. Halaska, Tomas Brtnicky, Lukas Rob, Jiri Presl, Jan Kostun, Isabelle Cremer, Ales Ryska, Guido Kroemer, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patientsJournal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0781-z
4
Lenka Kasikova, Iva Truxova, Isabelle Cremer, Catherine Sautes-Fridman, Oliver Kepp, Guido Kroemer, Radek Spisek, Jitka Fucikova. Tumor Immunology and Immunotherapy – Cellular Methods Part BMethods in Enzymology 2020; 632: 15 doi: 10.1016/bs.mie.2019.05.025
5
Abhishek D. Garg, Sanne Elsen, Dmitri V. Krysko, Peter Vandenabeele, Peter de Witte, Patrizia Agostinis. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removalOncotarget 2015; 6(29): 26841 doi: 10.18632/oncotarget.4754
6
Guido Kroemer, Lorenzo Galluzzi, Oliver Kepp, Laurence Zitvogel. Immunogenic Cell Death in Cancer TherapyAnnual Review of Immunology 2013; 31(1): 51 doi: 10.1146/annurev-immunol-032712-100008
7
Peter G. Alexander, Donald C. McMillan, James H. Park. The local inflammatory response in colorectal cancer – Type, location or density? A systematic review and meta-analysisCancer Treatment Reviews 2020; 83: 101949 doi: 10.1016/j.ctrv.2019.101949
8
Gregory E. Idos, Janet Kwok, Nirupama Bonthala, Lynn Kysh, Stephen B. Gruber, Chenxu Qu. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-AnalysisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60255-4
9
Jitka Fucikova, Iva Truxova, Michal Hensler, Etienne Becht, Lenka Kasikova, Irena Moserova, Sarka Vosahlikova, Jana Klouckova, Sarah E. Church, Isabelle Cremer, Oliver Kepp, Guido Kroemer, Lorenzo Galluzzi, Cyril Salek, Radek Spisek. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patientsBlood 2016; 128(26): 3113 doi: 10.1182/blood-2016-08-731737
10
Shubhankar Nath, Girgis Obaid, Tayyaba Hasan. The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T‐Cell RepertoirePhotochemistry and Photobiology 2019; 95(6): 1288 doi: 10.1111/php.13173
11
Lucy Jankova, Owen F. Dent, Mark P. Molloy, Charles Chan, Pierre H. Chapuis, Viive M. Howell, Stephen J. Clarke. Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelinesPROTEOMICS - Clinical Applications 2015; 9(11-12): 1078 doi: 10.1002/prca.201400177
12
Abhishek D. Garg, Dirk De Ruysscher, Patrizia Agostinis. Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysisOncoImmunology 2016; 5(2): e1069938 doi: 10.1080/2162402X.2015.1069938
13
Sylvain Ladoire, Laura Senovilla, David Enot, François Ghiringhelli, Vichnou Poirier-Colame, Kariman Chaba, Gulsun Erdag, Jochen T. Schaefer, Donna H. Deacon, Laurence Zitvogel, Craig L. Slingluff, Guido Kroemer. Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrateOncoImmunology 2016; 5(6): e1160193 doi: 10.1080/2162402X.2016.1160193
14
Lei Cai, Theodoros Michelakos, Teppei Yamada, Song Fan, Xinhui Wang, Joseph H. Schwab, Cristina R. Ferrone, Soldano Ferrone. Defective HLA class I antigen processing machinery in cancerCancer Immunology, Immunotherapy 2018; 67(6): 999 doi: 10.1007/s00262-018-2131-2
15
T Colangelo, G Polcaro, P Ziccardi, L Muccillo, M Galgani, B Pucci, M Rita Milone, A Budillon, M Santopaolo, G Mazzoccoli, G Matarese, L Sabatino, V Colantuoni. The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cellsCell Death & Disease 2016; 7(2): e2108 doi: 10.1038/cddis.2016.29
16
Mayram Amiri-Shoar, Masoumeh Hosseini, Mitra Arianmanesh, Reza Eghdam-Zamiri, Shahrokh Attarian, Ali Awsat Mellati. Comparative Proteomic Analysis of Breast Cancer Tissue and the Adjacent Normal Tissue in Iranian Patients with HER2 Negative Ductal Carcinoma of BreastInternational Journal of Cancer Management 2017; 10(5) doi: 10.5812/ijcm.6019
17
A D Garg, E Romano, N Rufo, P Agostinis. Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translationCell Death & Differentiation 2016; 23(6): 938 doi: 10.1038/cdd.2016.5
18
Matthew P. Rausch, Aparna Ranganathan Sertil. A Stressful Microenvironment: Opposing Effects of the Endoplasmic Reticulum Stress Response in the Suppression and Enhancement of Adaptive Tumor ImmunityInternational Reviews of Immunology 2015; 34(2): 104 doi: 10.3109/08830185.2015.1018415
19
Xiaoli Liu, Bin Yan, Yao Li, Xiaowei Ma, Wangbo Jiao, Kejian Shi, Tingbin Zhang, Shizhu Chen, Yuan He, Xing-Jie Liang, Haiming Fan. Graphene Oxide-Grafted Magnetic Nanorings Mediated Magnetothermodynamic Therapy Favoring Reactive Oxygen Species-Related Immune Response for Enhanced Antitumor EfficacyACS Nano 2020; 14(2): 1936 doi: 10.1021/acsnano.9b08320
20
Xu-Hua Zhang, Yue Zhang, Wen-Peng Xie, De-Sheng Sun, Yong-Kui Zhang, Yan-Ke Hao, Guo-Qing Tan. Expression and significance of calreticulin in human osteosarcomaCancer Biomarkers 2017; 18(4): 405 doi: 10.3233/CBM-160266
21
Udo Holtick, Nela Klein-Gonzalez, Michael S von Bergwelt-Baildon. Potential of Toll-like receptor 9 agonists in combined anticancer immunotherapy strategies: synergy of PAMPs and DAMPs?Immunotherapy 2011; 3(3): 301 doi: 10.2217/imt.10.118
22
Giada Gelsomino, Paola A Corsetto, Ivana Campia, Gigliola Montorfano, Joanna Kopecka, Barbara Castella, Elena Gazzano, Dario Ghigo, Angela M Rizzo, Chiara Riganti. Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes compositionMolecular Cancer 2013; 12(1): 137 doi: 10.1186/1476-4598-12-137
23
S. Martin, A.M. Dudek-Perić, H. Maes, A.D. Garg, M. Gabrysiak, S. Demirsoy, J.V. Swinnen, P. Agostinis. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cellsBiochemical Pharmacology 2015; 93(3): 290 doi: 10.1016/j.bcp.2014.12.003
24
Yi-Jun Wang, Rochelle Fletcher, Jian Yu, Lin Zhang. Immunogenic effects of chemotherapy-induced tumor cell deathGenes & Diseases 2018; 5(3): 194 doi: 10.1016/j.gendis.2018.05.003
25
Philipp Müller, Jonathan Rios-Doria, Jay Harper, Anthony Cao. Innovations for Next-Generation Antibody-Drug ConjugatesCancer Drug Discovery and Development 2018; : 11 doi: 10.1007/978-3-319-78154-9_2
26
C.S.D. Roxburgh, D.C. McMillan. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancerCancer Treatment Reviews 2012; 38(5): 451 doi: 10.1016/j.ctrv.2011.09.001
27
Laurence Zitvogel, Oliver Kepp, Guido Kroemer. Immune parameters affecting the efficacy of chemotherapeutic regimensNature Reviews Clinical Oncology 2011; 8(3): 151 doi: 10.1038/nrclinonc.2010.223
28
Barbara Ziffels, Anna Grötsch, Lubna Al-Bayati, Dario Neri. Targeted delivery of calreticulin to ED-A fibronectin leads to tumor-growth retardationJournal of Biotechnology 2019; 290: 53 doi: 10.1016/j.jbiotec.2018.12.007
29
Alfonso Serrano-del Valle, Alberto Anel, Javier Naval, Isabel Marzo. Immunogenic Cell Death and Immunotherapy of Multiple MyelomaFrontiers in Cell and Developmental Biology 2019; 7 doi: 10.3389/fcell.2019.00050
30
Heng Yang, Yuting Ma, Guo Chen, Heng Zhou, Takahiro Yamazaki, Christophe Klein, Federico Pietrocola, Erika Vacchelli, Sylvie Souquere, Allan Sauvat, Laurence Zitvogel, Oliver Kepp, Guido Kroemer. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapyOncoImmunology 2016; 5(6): e1149673 doi: 10.1080/2162402X.2016.1149673
31
Melanie J. McCoy, Anna K. Nowak, Richard A. Lake. Cell Death Signaling in Cancer Biology and Treatment2013; : 373 doi: 10.1007/978-1-4614-5847-0_14
32
Carolin Muth, Yvonne Rubner, Sabine Semrau, Paul-Friedrich Rühle, Benjamin Frey, Annedore Strnad, Rolf Buslei, Rainer Fietkau, Udo S. Gaipl. Primary glioblastoma multiforme tumors and recurrenceStrahlentherapie und Onkologie 2016; 192(3): 146 doi: 10.1007/s00066-015-0926-z
33
Jonathan M. Pitt, Guido Kroemer, Laurence Zitvogel. Tumor Immune Microenvironment in Cancer Progression and Cancer TherapyAdvances in Experimental Medicine and Biology 2017; 1036: 65 doi: 10.1007/978-3-319-67577-0_5
34
Jitka Fucikova, Lenka Kasikova, Iva Truxova, Jan Laco, Petr Skapa, Ales Ryska, Radek Spisek. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancerImmunology Letters 2018; 193: 25 doi: 10.1016/j.imlet.2017.11.006
35
Olga Vaksman, Ben Davidson, Claes Tropé, Reuven Reich. Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastasesHuman Pathology 2013; 44(12): 2677 doi: 10.1016/j.humpath.2013.07.009
36
Ruo Feng, Jianwen Ye, Chuang Zhou, Lei Qi, Zhe Fu, Bing Yan, Zhiwei Liang, Renfeng Li, Wenlong Zhai. Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cellsDiagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0382-1
37
T Colangelo, G Polcaro, P Ziccardi, B Pucci, L Muccillo, M Galgani, A Fucci, M R Milone, A Budillon, M Santopaolo, C Votino, M Pancione, A Piepoli, G Mazzoccoli, M Binaschi, M Bigioni, C A Maggi, M Fassan, C Laudanna, G Matarese, L Sabatino, V Colantuoni. Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancerCell Death & Disease 2016; 7(2): e2120 doi: 10.1038/cddis.2016.28
38
Darina Ocadlikova, Mariangela Lecciso, Alessandro Isidori, Federica Loscocco, Giuseppe Visani, Sergio Amadori, Michele Cavo, Antonio Curti. Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid LeukemiaFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01004
39
Gautier Stoll, Kristina Iribarren, Judith Michels, Alexandra Leary, Laurence Zitvogel, Isabelle Cremer, Guido Kroemer. Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancerOncoImmunology 2016; 5(7): e1177692 doi: 10.1080/2162402X.2016.1177692
40
Tina Riedel, Olivier Demaria, Olivier Zava, Ana Joncic, Michel Gilliet, Paul J. Dyson. Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma TreatmentMolecular Pharmaceutics 2018; 15(1): 116 doi: 10.1021/acs.molpharmaceut.7b00764
41
David A. Bernal-Estévez, Oscar García, Ramiro Sánchez, Carlos A. Parra-López. Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapyBMC Cancer 2018; 18(1) doi: 10.1186/s12885-017-3982-1
42
Abhishek D. Garg, Dmitri V. Krysko, Peter Vandenabeele, Patrizia Agostinis. DAMPs and PDT-mediated photo-oxidative stress: exploring the unknownPhotochemical & Photobiological Sciences 2011; 10(5): 670 doi: 10.1039/c0pp00294a
43
Maria Lie Lotsberg, Sandy Chen, Sushil Dhakal, James B. Lorens, Bruce Baguley, Salem Chouaib, Agnete S.T. Engelsen. Autophagy in Immune Response: Impact on Cancer Immunotherapy2020; : 119 doi: 10.1016/B978-0-12-819609-0.00008-0
44
Paul Eggleton, Edwin Bremer, Elzbieta Dudek, Marek Michalak. Calreticulin, a therapeutic target?Expert Opinion on Therapeutic Targets 2016; 20(9): 1137 doi: 10.1517/14728222.2016.1164695
45
Nicole Rufo, Abhishek D. Garg, Patrizia Agostinis. The Unfolded Protein Response in Immunogenic Cell Death and Cancer ImmunotherapyTrends in Cancer 2017; 3(9): 643 doi: 10.1016/j.trecan.2017.07.002
46
Seng-Ryong Woo, Leticia Corrales, Thomas F. Gajewski. Innate Immune Recognition of CancerAnnual Review of Immunology 2015; 33(1): 445 doi: 10.1146/annurev-immunol-032414-112043